Salvatore Michele Carnazzo | Neuroscience | Innovative Research Award

Published on by Cognitive Scientist Awards

Innovative Research Award

Salvatore Michele Carnazzo
Affiliation Università Kore di Enna
Country Italy
Scopus ID 58639973600
Documents 10
Citations 3
h-index 1
Subject Area Neuroscience
Event International Cognitive Scientist Awards
ORCID 0009-0006-2557-9559

Salvatore Michele Carnazzo
Università Kore di Enna, Italy.

Salvatore Michele Carnazzo is affiliated with Università Kore di Enna, Italy, and is recognized within the field of neuroscience through scholarly contributions documented in international academic databases. The present profile summarizes research activities, publication records, citation indicators, and academic engagement relevant to consideration for the Innovative Research Award.[1]

Abstract

This academic recognition profile presents a structured overview of the scholarly activities of Salvatore Michele Carnazzo. The profile evaluates research visibility, publication output, citation indicators, and thematic engagement within neuroscience. The information is organized in a format commonly used for academic award assessments and professional recognition processes.[1][2]

Keywords

Neuroscience, Cognitive Science, Scientific Research, Academic Publications, Citation Analysis, Research Evaluation, Scholarly Impact, International Awards, Scientific Communication, Research Recognition.

Introduction

Recognition programs within the scientific community frequently evaluate researchers using measurable indicators such as publication productivity, citation performance, scholarly visibility, and participation in specialized research domains. In neuroscience, these indicators contribute to understanding the scope and influence of individual research efforts. Salvatore Michele Carnazzo’s documented academic record provides evidence of engagement in research dissemination and scientific communication activities relevant to contemporary neuroscience scholarship.[1]

Research Profile

According to available author-indexed records, Salvatore Michele Carnazzo has contributed scholarly works associated with neuroscience-related themes. Academic metrics indicate a publication portfolio consisting of ten indexed documents accompanied by citation activity and an h-index value of one. These indicators provide a quantitative overview of research dissemination and visibility within the scientific literature.[1]

The research profile demonstrates participation in scholarly publishing and engagement with scientific communication channels that contribute to knowledge exchange within the broader neuroscience community.[2]

Research Contributions

The documented body of work reflects involvement in neuroscience-oriented investigations and scientific reporting. Contributions in this area support the advancement of understanding related to cognitive and neurological processes through evidence-based inquiry and academic dissemination. Such activities contribute to the cumulative development of scientific knowledge and foster collaboration among researchers working in related domains.[3]

Research contributions are commonly evaluated not only through publication counts but also through methodological rigor, relevance of findings, and the capacity to stimulate further academic discussion. The available record indicates active participation in these scholarly processes.[4]

Publications

The publication portfolio associated with Salvatore Michele Carnazzo includes peer-reviewed academic outputs indexed within recognized scholarly databases. Publication activity serves as an important indicator of scientific engagement and demonstrates participation in the dissemination of research findings to the international academic community.[1]

  • Indexed scientific articles in neuroscience-related subject areas.
  • Research outputs contributing to scholarly communication.
  • Publications accessible through international academic indexing systems.
  • Research dissemination supporting knowledge development and academic exchange.

Research Impact

Research impact can be assessed through citation activity, publication visibility, and engagement within the scientific community. Citation records associated with the documented publications indicate that the research outputs have attracted scholarly attention and have been referenced in subsequent academic works. Although citation metrics represent only one dimension of research quality, they provide useful evidence of academic reach and influence.[1][5]

Award Suitability

Based on available academic indicators, Salvatore Michele Carnazzo demonstrates characteristics commonly considered during evaluations for research recognition programs. These include documented publication activity, measurable citation performance, institutional affiliation, and active engagement within the neuroscience research landscape. Such factors align with the objectives of the Innovative Research Award, which seeks to acknowledge scholarly dedication and contributions to scientific advancement.[1]

Conclusion

Salvatore Michele Carnazzo’s academic profile reflects participation in neuroscience research and scholarly communication through indexed publications and citation activity. The available evidence highlights engagement with scientific inquiry and contribution to academic discourse. This profile provides a concise overview of achievements relevant to consideration for the Innovative Research Award within the framework of the International Cognitive Scientist Awards.[1][2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Salvatore Michele Carnazzo, Author ID 58639973600. Scopus Author Profile.
    https://www.scopus.com/authid/detail.uri?authorId=58639973600
  2. ORCID. (n.d.). ORCID Record for Salvatore Michele Carnazzo.
    https://orcid.org/0009-0006-2557-9559
  3. Kandel, E. R., Schwartz, J. H., Jessell, T. M. (2013). Principles of Neural Science.
  4. Purves, D. et al. (2018). Neuroscience. Oxford University Press.
  5. Bornmann, L., Daniel, H. D. (2008). What do citation counts measure? Journal of Documentation.

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAward  🏆

Principal Scientist of Cognitive Health at DSM-Firmenich, RD Innovation
Switzerland🎓

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional Profile 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

Skills 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

 Membership 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications : 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    🔬 The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    💊 The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179